Recent Updates — BIOX

On September 18, 2026, the Supreme Court of New York granted Plaintiffs' motion for summary judgment in Jasper Lake Ventures One LLC v. Bioceres Crop Solutions Corp., awarding damages as requested by the plaintiffs plus $1.4 million in costs and attorneys’ fees. The court also awarded per diem interest from July 23, 2026, until judgment entry. Bioceres intends to appeal this ruling. This company operates in the agricultural biotechnology industry, developing crop protection products.

Bioceres Crop Solutions Corp. reported fiscal fourth quarter and full-year 2026 results, with Q4 revenues of $55.9 million and full-year revenues declining 18% to $238.3 million due to the reconfiguration of its Seeds business. The company returned to positive Adjusted EBITDA in Q4 at $0.6 million, driven by a 19% reduction in SG&A expenses, though it reported a net loss from continuing operations of $31.8 million for the quarter and $54.4 million for the year. Concurrently, Nasdaq approved Bioceres' transfer to The Nasdaq Capital Market effective September 18, 2026, granting an additional 180-day compliance period until March 15, 2027, to regain the minimum $1.00 bid price requirement or implement a reverse stock split. Bioceres Crop Solutions Corp. operates in the agricultural technology industry, developing and commercializing productivity solutions such as microbial ag-inputs and crop nutrition products.